These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 15959831)

  • 41. Prenatal lead exposure enhances methamphetamine sensitization in rats.
    Clifford PS; Hart N; Thompson J; Buckman S; Wellman PJ; Bratton GR; Nation JR
    Pharmacol Biochem Behav; 2009 Aug; 93(2):165-9. PubMed ID: 19433104
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of dopamine receptor antagonist on in vivo dopamine release induced by intrastriatal perfusion with methamphetamine in freely moving rats.
    Watanabe H; Sekihara S; Nomura Y
    Methods Find Exp Clin Pharmacol; 1989 Feb; 11(2):81-5. PubMed ID: 2709920
    [TBL] [Abstract][Full Text] [Related]  

  • 43. GZ-11608, a Vesicular Monoamine Transporter-2 Inhibitor, Decreases the Neurochemical and Behavioral Effects of Methamphetamine.
    Lee NR; Zheng G; Leggas M; Janganati V; Nickell JR; Crooks PA; Bardo MT; Dwoskin LP
    J Pharmacol Exp Ther; 2019 Nov; 371(2):526-543. PubMed ID: 31413138
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vivo neurochemical and anatomical heterogeneity of the dopamine uptake system in the rat caudate putamen.
    Glynn GE; Yamamoto BK
    Brain Res; 1989 Mar; 481(2):235-41. PubMed ID: 2524237
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Methamphetamine-induced neurotoxicity alters locomotor activity, stereotypic behavior, and stimulated dopamine release in the rat.
    Wallace TL; Gudelsky GA; Vorhees CV
    J Neurosci; 1999 Oct; 19(20):9141-8. PubMed ID: 10516332
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A single exposure to morphine induces long-lasting hyporeactivity of rat caudate putamen dopaminergic nerve terminals.
    Pereira FC; Santos SD; Ribeiro CF; Ali SF; Macedo TR
    Ann N Y Acad Sci; 2004 Oct; 1025():414-23. PubMed ID: 15542744
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of the effects of nicotine and epibatidine on the striatal extracellular dopamine.
    Janhunen S; Ahtee L
    Eur J Pharmacol; 2004 Jun; 494(2-3):167-77. PubMed ID: 15212971
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influence of acute and chronic haloperidol treatment on dopamine metabolism in the rat caudate-putamen, prefrontal cortex and amygdala.
    Essig EC; Kilpatrick IC
    Psychopharmacology (Berl); 1991; 104(2):194-200. PubMed ID: 1876664
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Escalating dose-binge treatment with methylphenidate: role of serotonin in the emergent behavioral profile.
    Segal DS; Kuczenski R
    J Pharmacol Exp Ther; 1999 Oct; 291(1):19-30. PubMed ID: 10490882
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chronic benzylpiperazine (BZP) exposure produces behavioral sensitization and cross-sensitization to methamphetamine (MA).
    Brennan K; Johnstone A; Fitzmaurice P; Lea R; Schenk S
    Drug Alcohol Depend; 2007 May; 88(2-3):204-13. PubMed ID: 17125936
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased dopamine metabolism in the rat neostriatum after toxic doses of d-methylamphetamine.
    Ricaurte GA; Seiden LS; Schuster CR
    Neuropharmacology; 1983 Dec; 22(12A):1383-8. PubMed ID: 6664467
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Striatal dopamine nerve terminal markers in human, chronic methamphetamine users.
    Wilson JM; Kalasinsky KS; Levey AI; Bergeron C; Reiber G; Anthony RM; Schmunk GA; Shannak K; Haycock JW; Kish SJ
    Nat Med; 1996 Jun; 2(6):699-703. PubMed ID: 8640565
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Persistent behavioral and neurochemical sensitization to an acute injection of methamphetamine following unpredictable stress.
    Matuszewich L; Carter S; Anderson EM; Friedman RD; McFadden LM
    Behav Brain Res; 2014 Oct; 272():308-13. PubMed ID: 25036423
    [TBL] [Abstract][Full Text] [Related]  

  • 54. l-methamphetamine pharmacokinetics and pharmacodynamics for assessment of in vivo deprenyl-derived l-methamphetamine.
    Melega WP; Cho AK; Schmitz D; Kuczenski R; Segal DS
    J Pharmacol Exp Ther; 1999 Feb; 288(2):752-8. PubMed ID: 9918585
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reversal of methamphetamine-induced behavioral sensitization by repeated administration of a dopamine D1 receptor agonist.
    Shuto T; Kuroiwa M; Hamamura M; Yabuuchi K; Shimazoe T; Watanabe S; Nishi A; Yamamoto T
    Neuropharmacology; 2006 Jun; 50(8):991-7. PubMed ID: 16563442
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dose-Dependent Effects of Binge-Like Methamphetamine Dosing on Dopamine and Neurotrophin Levels in Rat Brain.
    Moreira da Silva Santos A; Kelly JP; Doyle KM
    Neuropsychobiology; 2017; 75(2):63-71. PubMed ID: 29065400
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of chronic methamphetamine on the nigral-striatal dopamine system in rat brain: tyrosine hydroxylase immunochemistry and quantitative light microscopic studies.
    Trulson ME; Cannon MS; Faegg TS; Raese JD
    Brain Res Bull; 1985 Dec; 15(6):569-77. PubMed ID: 2867819
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dopamine efflux during withdrawal from continuous or intermittent cocaine.
    King GR; Kuhn C; Ellinwood EH
    Psychopharmacology (Berl); 1993; 111(2):179-84. PubMed ID: 7870949
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MK-801 prevents methamphetamine-induced striatal dopamine damage and reduces extracellular dopamine overflow.
    O'Dell SJ; Weihmuller FB; Marshall JF
    Ann N Y Acad Sci; 1992 May; 648():317-9. PubMed ID: 1637061
    [No Abstract]   [Full Text] [Related]  

  • 60. The effect of repeated administration of methamphetamine on dopamine uptake sites in rat striatum.
    Ikawa K; Watanabe A; Motohashi N; Kaneno S
    Neurosci Lett; 1994 Feb; 167(1-2):37-40. PubMed ID: 8177527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.